Vikram Karnani

Vikram Karnani

Chief Executive Officer at COLLEGIUM PHARMACEUTICAL, INC.

Net worth: 962 768 $ as of 30/08/2026

51 year
Health Technology
Consumer Services

Profile

Vikram Karnani is President, Chief Executive Officer & Director at Collegium Pharmaceutical, Inc. since 2024.
Mr. Karnani is Independent Director at Dyne Therapeutics, Inc. starting in 2025.
Former roles include VP-Therapeutics & Cell Therapy Business at Fresenius Kabi USA LLC from 2011 to 2014, Chief Commercial Officer & Executive VP at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020, and President-Commercial Operations & Medical Affairs at Amgen, Inc. Education includes graduate studies at Case Western Reserve University, undergraduate studies at the University of Mumbai, and an MBA from Kellogg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/03/2026 39,121 ( 0.12% ) 962 768 $ 30/08/2026
31/03/2026 0 ( -.--% ) - $ 30/08/2026

Vikram Karnani active positions

CompaniesPositionStart
COLLEGIUM PHARMACEUTICAL, INC. Chief Executive Officer 11/11/2024
DYNE THERAPEUTICS, INC. Director/Board Member 21/12/2025

Former positions of Vikram Karnani

CompaniesPositionEnd
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Chief Tech/Sci/R&D Officer 31/10/2023
Corporate Officer/Principal 31/07/2014
AMGEN INC. Chief Tech/Sci/R&D Officer -
See the detail of Vikram Karnani's experience

Training of Vikram Karnani

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Vikram Karnani